SCYX FY 2021 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena

SCYXSCYNEXIS, Inc.

$37M

FY 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$13M

Gross Profit

$13M97.6% margin

Operating Income

-$61M-462.2% margin

Net Income

-$33M-249.7% margin

EPS (Diluted)

$-1.25

Cash Flow

Operating Cash Flow

-$55M

Free Cash Flow

-$56M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$120M

Total Liabilities

$79M

Stockholders' Equity

$41M

Cash & Equivalents

$104M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$0	—
Gross Profit	$13M	-$303,000	+4341.3%
Operating Income	-$61M	-$51M	-18.9%
Net Income	-$33M	-$55M	+40.4%